Progressive Familial Intrahepatic Cholestasis (PFIC)
Also known as: Progressive Familial Intrahepatic Cholestasis / Progressive intrahepatic cholestasis (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB16226 | Maralixibat | An ileal bile acid transporter inhibitor indicated to treat cholestatic pruritus in patients with Alagille syndrome. |
| DB16261 | Odevixibat | An ileal sodium/bile acid cotransporter inhibitor indicated in the treatment of pruritus in patients with progressive familial intrahepatic cholestasis. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01432 | Cholestyramine | 1 | Completed | 1 |
| DB16261 | Odevixibat | 1 | Completed | 2 |
| DB16226 | Maralixibat | 2 | Active Not Recruiting | 1 |
| DB16226 | Maralixibat | 2 | Completed | 1 |
| DB16226 | Maralixibat | 3 | Active Not Recruiting | 2 |
| DB16226 | Maralixibat | 3 | Completed | 1 |
| DB16226 | Maralixibat | 3 | Withdrawn | 1 |
| DB16261 | Odevixibat | 3 | Active Not Recruiting | 1 |
| DB16261 | Odevixibat | Not Available | Approved for Marketing | 1 |